Kincell Bio, LLC
Kincell Bio is an early-stage cell therapy partner providing contract development and manufacturing (CDMO) services for innovator biotech and academic spinout companies. Our focus is on helping companies identify their key value propositions, develop their product CMC strategy, and then execute on it. This is accomplished through CMC consulting, guidance to build an appropriate Target Product Profile (TPP) to support the desired clinical POC and then support downstream process and analytical development, IND-enabling activities and cGMP manufacturing support for Phase 1/2 clinical trials. In addition to longstanding collective expertise in the early development of autologous cell therapies, our team brings a strong culture of collaboration and interaction. As a service provider that was carved out of an innovator biotech, our team understands the mindset associated developing complex products for clinical study. We are keen to share this insight and mindset with our clients and partners to advance their programs into clinical studies. With connections across the industry and an ecosystem of partner companies, we can quickly identify opportunities to develop client programs and technologies into mature processes and analytical methods to support hypothesis driven clinical investigation. These ecosystem partners include companies with expertise in viral vector development and manufacturing, testing services, facility design and PD/AD consulting expertise and formulations and fill/finish strategies.
